Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 11, 2001, Pages 1827-1836

  Colpaert, S ^a   Liu, Z ^a   De Greef, B ^a   Rutgeerts, P ^a   Ceuppens, J L ^a   Geboes, K ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; EDETATE CHROMIUM CR 51; INDOMETACIN; INTERLEUKIN 10; METRONIDAZOLE; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; DRUG POTENCY; FEMALE; HEMOGLOBIN DETERMINATION; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZTREONAM; BACTERIA, ANAEROBIC; CROHN DISEASE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FEMALE; INDOMETHACIN; INFLAMMATION; INTERLEUKIN-10; METRONIDAZOLE; MONOBACTAMS; PERMEABILITY; RATS; RATS, WISTAR; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034773287     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01111.x     Document Type: Article

References (47)

1. Ulcerative enterocolitis in dogs induced by drugs
2. Small intestinal ulcers and intestinal flora in rats given indomethacin
3. Meta-analysis of risk of gastrointestinal complications with NSAIDs. Narrative review should have been used
4. Similarities between ileal Crohn's disease and indomethacin experimental jejunal ulcers in the rat
5. Clustering of increased small intestinal permeability in families with Crohn's disease
6. Assessment of intestinal permeability changes induced by nonsteroidal anti-inflammatory drugs in the rat
7. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: A review and a hypothesis
8. Abnormalities of cell-membrane fluidity in the pathogenesis of disease
9. Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity
10. Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat
11. Differential effects of ibuprofen and indomethacin in the regional circulation of the dog
12. Nonsteroidal anti-inflammatory drug enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation
13. Indomethacin-induced intestinal lesions in the rat
14. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin
15. Bile secretion in rats with indomethacin-induced intestinal inflammation
16. Glucose and citrate reduce the permeability changes caused by indomethacin in humans
17. Effect of glutamine on the intestinal permeability changes induced by indomethacin in humans
18. Indomethacin-induced gastrointestinal ulcers in rats: Effects of dietary fatty acids and endotoxin
19. Effects of diet on experimentally induced intestinal ulcers in rats: Morphology and tissue leukotrienes
20. Lactulose and neomycin attenuate leukocyte-endothelial cell adhesion in an animal model of inflammatory bowel disease
21. Leucocyte endothelial cell adhesion in indomethacin induced intestinal inflammation is correlated with faecal pH
22. Protective effect of lactosucrose on intracolonic indomethacin-induced small-intestinal ulcers in rats
23. Resistance of germfree rats to indomethacin-induced intestinal lesions
24. Role of bacteria in gastric ulceration produced by indomethacin in the rat: Cytoprotective action of antibiotics
25. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats
26. Effects of metronidazole and misoprostol on indomethacin-induced changes in intestinal permeability
27. Pharmacological protection of NSAID-induced intestinal permeability in the rat: Effect of tempo and metronidazole as potential free radical scavengers
28. Metronidazole inhibits leukocyte-endothelial cell adhesion in rat mesenteric venules
29. Experimental enteropathy in athymic and euthymic rats: Synergistic role of lipopolysaccharide and indomethacin
30. Leucocyte-endothelial cell adhesion in a model of intestinal inflammation
31. Role of interleukin 8 on leucocyte-endothelial cell adhesion in intestinal inflammation
32. Acute indomethacin-induced jejunal injury in the rat: Early morphological and biochemical changes
33. Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the rat
34. Indomethacin-induced intestinal ulcers are associated with an increased number of peripheral T lymphocytes in the rat
35. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
36. Increase in tumor necrosis factor-α production linked to the toxicity of indomethacin for the rat small intestine
37. Tumour necrosis factor and Crohn's disease
38. Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors
39. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors
40. A membrane TNF-alpha/TNFR ratio correlates to MODS score and mortality
41. Increased leptin expression in mice with bacterial peritonitis is partially regulated by tumor necrosis factor alpha
42. Role of cytokines in experimental colitis: Relation to intestinal permeability
43. Interleukin 10 gene transfer prevents experimental colitis in rats
44. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
45. IL-10 enhances IL-2-induced proliferation and cytotoxicity by human intestinal lymphocytes
46. Anti- but also proinflammatory effects of interleukin-10 in mild to moderate Crohn's disease
47. Proinflammatory effects of IL-10 in pathological ileal Crohn's disease